Literature DB >> 2656583

Renal cell carcinoma with metastasis to the parotid gland: case reports and review of the literature.

R M Owens1, C D Friedman, S P Becker.   

Abstract

Two cases of renal cell carcinoma metastatic to the parotid gland are presented. The parotid mass was the initial manifestation of the first patient's renal cell malignancy and the pathologic evaluation was the first clue to the diagnosis. The second case demonstrates discovery of metastasis to the parotid gland 8 years after resection of a hypernephroma. A review of the literature on this subject is presented and the pathologic characteristics as well as recommendations for diagnosis and treatment of this entity are reviewed.

Entities:  

Mesh:

Year:  1989        PMID: 2656583     DOI: 10.1002/hed.2880110212

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neck.

Authors:  M B Paiva; J A Sercarz; A J Pantuck; M Polyakov; R A Figlin; R F Canalis; D J Castro
Journal:  Lasers Med Sci       Date:  2007-01-12       Impact factor: 3.161

2.  p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.

Authors:  Jonathan B McHugh; Aaron P Hoschar; Mari Dvorakova; Anil V Parwani; E Leon Barnes; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2007-10-26

Review 3.  Histopathological findings in parotid gland metastases from renal cell carcinoma.

Authors:  Roderik Mrena; Ilmo Leivo; Fabricio Passador-Santos; Jaana Hagström; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-26       Impact factor: 2.503

4.  Rapidly growing and ulcerating metastatic renal cell carcinoma of the lower lip: A case report and review of the literature.

Authors:  Juho Suojanen; Esa Färkkilä; Tessa Helkamaa; Venla Loimu; Jyrki Törnwall; Christian Lindqvist; Jaana Hagström; Karri Mesimäki
Journal:  Oncol Lett       Date:  2014-09-05       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.